Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme - Related Studies

Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

This study has been completed.

Study NCT00128635. Last updated on May 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Central Nervous System Neoplasms
		Glioblastoma
		Nervous System Neoplasms

2	More general conditions related to this trial
		Astrocytoma
		Glioma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Nervous System Diseases
		Neuroectodermal Tumors

3	Additional drug interventions recognized in this trial
		Antibodies
		Antibodies, Monoclonal

4	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

5	Sponsors listed in this trial
		National Cancer Institute (NCI)